JP2006503588A5
(cg-RX-API-DMAC7.html )
2006-10-19
JP2004514647A5
(cg-RX-API-DMAC7.html )
2012-06-21
JP2004535435A5
(cg-RX-API-DMAC7.html )
2006-01-05
JP2007518723A5
(cg-RX-API-DMAC7.html )
2008-02-28
JP2006006329A5
(cg-RX-API-DMAC7.html )
2007-01-18
JP2006096962A5
(cg-RX-API-DMAC7.html )
2009-01-22
JP2005514410A5
(cg-RX-API-DMAC7.html )
2006-02-23
JP2008507556A5
(cg-RX-API-DMAC7.html )
2008-09-04
JP2006524283A5
(cg-RX-API-DMAC7.html )
2007-05-10
JP2007515544A5
(cg-RX-API-DMAC7.html )
2007-12-27
JP2005529833A5
(cg-RX-API-DMAC7.html )
2006-06-15
JP2004538039A5
(cg-RX-API-DMAC7.html )
2007-11-29
DK1381590T3
(da )
2007-10-22
3,4-disubstituerede cyclobuten-1,2-dioner som CXC-kemokinreceptorligander
JP2009520180A5
(cg-RX-API-DMAC7.html )
2012-01-26
JP2005510235A5
(cg-RX-API-DMAC7.html )
2006-01-05
DE602004024828D1
(de )
2010-02-04
Benutzereingeleitete weiterreichung auf der basis des session-initiation-protokolls (sip)
ATE465995T1
(de )
2010-05-15
N-'(1,5-diphenyl-1h-pyrazol-3- yl)sulfonamidderivate mit affinität zum cb1- rezeptor
JP2006506499A5
(cg-RX-API-DMAC7.html )
2006-10-12
JP2007513049A5
(cg-RX-API-DMAC7.html )
2007-11-01
JP2002240244A5
(cg-RX-API-DMAC7.html )
2005-06-09
AR028248A1
(es )
2003-04-30
Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol
JP2004520815A5
(cg-RX-API-DMAC7.html )
2005-04-07
JP2007518719A5
(cg-RX-API-DMAC7.html )
2007-12-13
JP2007523200A5
(cg-RX-API-DMAC7.html )
2008-12-25
ITTO20020005A1
(it )
2003-07-04
Motociclo.